Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2025 filings

All 96 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2025, sourced directly from the official regulator.

96 Filings
2025 Period
2025 filings (96)
Filing Released Lang
Successful OncoSil Device Production at New Sydney Facility 2 pages 154.5KB
Regulatory Filings
2025-12-16 English
Notification of cessation of securities - OSL 4 pages 15.0KB
Share Issue/Capital Change
2025-12-10 English
First OncoSil treatment in United Kingdom 2 pages 168.0KB
Regulatory Filings
2025-12-09 English
OSPREY Analysis Shows Survival Benefit for OncoSil Patients 3 pages 287.5KB
Regulatory Filings
2025-12-02 English
Change of Director's Interest Notice x3 6 pages 366.3KB
Director's Dealing
2025-12-01 English
Application for quotation of securities - OSL 6 pages 19.2KB
Share Issue/Capital Change
2025-11-30 English
Notification regarding unquoted securities - OSL 8 pages 25.7KB
Share Issue/Capital Change
2025-11-30 English
Notification of cessation of securities - OSL 4 pages 15.0KB
Regulatory Filings
2025-11-20 English
Final Director's Interest Notice 2 pages 282.0KB
Director's Dealing
2025-11-20 English
Investor presentation - Bell Potter Healthcare Conference 21 pages 2.4MB
Investor Presentation
2025-11-19 English
AGM Chairman's Address and CEO & MD Presentation 24 pages 2.0MB
AGM Information
2025-11-18 English
Results of Meeting 2 pages 179.9KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-18 English
Retirement of Non-Executive Director 2 pages 180.4KB
Board/Management Information
2025-11-02 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 515.1KB
Interim / Quarterly Report Q1 2026
2025-10-29 English
Response to ASX Query Letter 6 pages 457.2KB
Regulatory Filings
2025-10-27 English
Annual Report (Typeset) 81 pages 2.1MB
Annual Report FY 2025
2025-10-22 English
Notification of cessation of securities - OSL 4 pages 14.9KB
Transaction in Own Shares
2025-10-21 English
Notice of Annual General Meeting/Proxy Form 34 pages 1.4MB
AGM Information
2025-10-19 English
First OncoSil treatment in Germany 2 pages 158.2KB
Regulatory Filings
2025-10-15 English
First OncoSil treatment in Portugal 2 pages 181.6KB
Regulatory Filings
2025-10-02 English
Response to ASX Aware Letter 6 pages 1.1MB
Regulatory Filings
2025-09-28 English
Change in substantial holding from SOL 7 pages 579.0KB
Major Shareholding Notification
2025-09-24 English
Positive Preliminary Results from PANCOSIL Phase 1-2 Study 4 pages 192.0KB
Regulatory Filings
2025-09-17 English
Investor Webinar Presentation 14 pages 1.1MB
Investor Presentation
2025-09-17 English
Trading Halt 2 pages 294.6KB
Regulatory Filings
2025-09-16 English
Investor Webinar Invitation 2 pages 526.3KB
Investor Presentation
2025-09-16 English
Notice of AGM date 2 pages 159.4KB
AGM Information
2025-09-11 English
Notice Under Section 708A 2 pages 203.9KB
Capital/Financing Update
2025-09-09 English
OncoSil announces new Non-Executive Chairman 3 pages 201.9KB
Board/Management Information
2025-09-08 English
Application for quotation of securities - OSL 6 pages 18.3KB
Share Issue/Capital Change
2025-09-08 English
PANCOSIL trial results to be presented at CIRSE meeting 2 pages 224.3KB
Regulatory Filings
2025-09-04 English
Change of Registered Office Address 2 pages 514.1KB
Regulatory Filings
2025-09-03 English
Company Secretary Appointment/Resignation 2 pages 516.8KB
Board/Management Information
2025-08-31 English
Appendix 4E and Annual Report 66 pages 999.2KB
Annual Report FY 2025
2025-08-28 English
Appendix 4G and Corporate Governance Statement 20 pages 616.0KB
Regulatory Filings
2025-08-28 English
Application for quotation of securities - OSL 6 pages 18.7KB
Share Issue/Capital Change
2025-08-21 English
Investor Webinar Invitation 2 pages 163.2KB
Investor Presentation
2025-08-06 English
Investor Webinar Presentation 17 pages 1.5MB
Investor Presentation
2025-08-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 546.7KB
Interim / Quarterly Report Q4 2025
2025-07-28 English
Completion of Recruitment in TRIPP-FFX Clinical Trial 2 pages 114.7KB
Regulatory Filings
2025-07-22 English
Appointment and Resignation of Company Secretary 2 pages 158.5KB
Board/Management Information
2025-07-22 English
Application for quotation of securities - OSL 7 pages 20.9KB
Share Issue/Capital Change
2025-07-14 English
Change in substantial holding from PCG 3 pages 432.9KB
Major Shareholding Notification
2025-07-14 English
Change in substantial holding from SOL 7 pages 494.5KB
Major Shareholding Notification
2025-07-14 English
OncoSil announces appointment of Non-Executive Director 2 pages 107.4KB
Board/Management Information
2025-07-10 English
Application for quotation of securities - OSL 8 pages 25.0KB
Capital/Financing Update
2025-07-10 English
Application for quotation of securities - OSL 11 pages 35.1KB
Capital/Financing Update
2025-07-10 English
OSLOD Options Range of Units and Top 20 Holders 3 pages 237.1KB
Major Shareholding Notification
2025-07-10 English
Initial Director's Interest Notice 2 pages 120.7KB
Director's Dealing
2025-07-10 English
Final Director's Interest Notice 2 pages 127.1KB
Director's Dealing
2025-07-10 English
Update - Proposed issue of securities - OSL 8 pages 27.6KB
Capital/Financing Update
2025-07-08 English
Update - Proposed issue of securities - OSL 7 pages 26.8KB
Capital/Financing Update
2025-07-08 English
Proposed issue of securities - OSL 6 pages 22.0KB
Capital/Financing Update
2025-07-08 English
Results of Meeting 2 pages 171.7KB
Declaration of Voting Results & Voting Rights Announcements
2025-07-07 English
OSL completes $2 million Share Purchase Plan 2 pages 83.7KB
Capital/Financing Update
2025-07-06 English
Completion of Recruitment in PANCOSIL Study 2 pages 115.1KB
Regulatory Filings
2025-07-03 English
Change of Directors Interest Notice Lel Smits 2 pages 282.0KB
Director's Dealing
2025-06-24 English
Notification regarding unquoted securities - OSL 7 pages 21.8KB
Share Issue/Capital Change
2025-06-18 English
Notification of cessation of securities - OSL 4 pages 14.9KB
Share Issue/Capital Change
2025-06-18 English
Change in substantial holding from SOL 8 pages 737.9KB
Regulatory Filings
2025-06-17 English
Change in substantial holding from PCG 4 pages 216.5KB
Regulatory Filings
2025-06-16 English
Capital Consolidation Complete 2 pages 96.0KB
Share Issue/Capital Change
2025-06-05 English
Update - Consolidation/Split - OSL 6 pages 22.8KB
Share Issue/Capital Change
2025-06-05 English
Notice of Extraordinary General Meeting/Proxy Form 26 pages 542.3KB
Proxy Solicitation & Information Statement
2025-06-05 English
Security Purchase Plan (SPP) Now Open 2 pages 80.4KB
Capital/Financing Update
2025-06-03 English
Application for quotation of securities - OSL 6 pages 18.4KB
Share Issue/Capital Change
2025-06-02 English
Notice under section 708A 1 page 74.6KB
Regulatory Filings
2025-06-02 English
Results of Meeting 2 pages 139.4KB
Declaration of Voting Results & Voting Rights Announcements
2025-05-28 English
Update - Consolidation/Split - OSL 6 pages 22.7KB
Share Issue/Capital Change
2025-05-28 English
OSL announces $8.7m capital raise to drive commercialisation 7 pages 162.1KB
Capital/Financing Update
2025-05-25 English
Prospectus 55 pages 760.8KB
Capital/Financing Update
2025-05-25 English
Investor Presentation 29 pages 1.4MB
Investor Presentation
2025-05-25 English
Proposed issue of securities - OSL 5 pages 18.1KB
Capital/Financing Update
2025-05-25 English
Proposed issue of securities - OSL 7 pages 26.1KB
Capital/Financing Update
2025-05-25 English
Proposed issue of securities - OSL 8 pages 27.1KB
Capital/Financing Update
2025-05-25 English
Trading Halt 2 pages 174.0KB
Capital/Financing Update
2025-05-21 English
OncoSil Outperforms SBRT in Pancreatic Cancer Outcomes 2 pages 96.3KB
Regulatory Filings
2025-05-06 English
Application for quotation of securities - OSL 6 pages 18.2KB
Share Issue/Capital Change
2025-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report Addendum 12 pages 759.5KB
Interim / Quarterly Report Q3 2025
2025-05-01 English
Consolidation/Split - OSL 6 pages 22.1KB
Share Issue/Capital Change
2025-04-30 English
Update - Consolidation/Split - OSL 6 pages 22.7KB
Share Issue/Capital Change
2025-04-30 English
Notice of Extraordinary General Meeting/Proxy Form 26 pages 684.8KB
Proxy Solicitation & Information Statement
2025-04-29 English
Tender Process for CRO to Undertake G-BA Study Commences 2 pages 91.7KB
Regulatory Filings
2025-04-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 747.5KB
Interim / Quarterly Report Q3 2025
2025-04-28 English
Appointment of Company Secretary 1 page 130.6KB
Board/Management Information
2025-03-31 English
OncoSil appoints Ms Shelley Steyn as Chief Financial Officer 2 pages 119.8KB
Board/Management Information
2025-03-17 English
Appendix 4D and Half Year Accounts 27 pages 796.5KB
Interim / Quarterly Report H1 2025
2025-02-24 English
Investor Webinar Presentation 10 pages 653.1KB
Investor Presentation
2025-02-10 English
Investor Webinar 11 February 2025 2 pages 165.2KB
Investor Presentation
2025-02-06 English
120 German Hospitals entitled to negotiate fee for OncoSil 2 pages 167.3KB
Regulatory Filings
2025-02-03 English
Response to Appendix 3X Query 3 pages 764.6KB
Regulatory Filings
2025-01-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 605.8KB
Interim / Quarterly Report Q2 2025
2025-01-29 English
Initial Director's Interest Notice LS 2 pages 222.4KB
Director's Dealing
2025-01-28 English
OncoSil Medical Receives MDR Approval 2 pages 217.0KB
Regulatory Filings
2025-01-27 English
Lel Smits to be appointed Non-Executive Director 2 pages 220.4KB
Board/Management Information
2025-01-14 English
OncoSil receives $1.05m R&D tax incentive 1 page 12
Capital/Financing Update
2025-01-07 English